Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study

<div>Patient clinical symptoms at baseline (visit 1) and the postbaseline visits and improvement/recovery during the course of the study. (a) Patients with symptoms at baseline, visit 2, and visit 3. (b) Days to the overall improvement and recovery of symptoms.</div>

Canadian Respiratory Journal

fig2

Figure 2

Figure 2: Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study 

Figure 2 | Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study 